2020 专家组建议:癌症治疗引起皮肤不良事件

2020-02-15 An Bras Dermatol. 2020 Feb 15

随着肿瘤治疗方法的不断发展,全身性毒性对生存率的影响得到了改善。不过值得注意的是皮肤不良事件。本文主要针对肿瘤治疗过程中引起的皮肤不良事件的管理提出指导建议。

中文标题:

2020 专家组建议:癌症治疗引起皮肤不良事件

英文标题:

Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.

发布机构:

发布日期:

2020-02-15

简要介绍:

随着肿瘤治疗方法的不断发展,全身性毒性对生存率的影响得到了改善。不过值得注意的是皮肤不良事件。本文主要针对肿瘤治疗过程中引起的皮肤不良事件的管理提出指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=3cbdb1c001882ac8, title=2020 专家组建议:癌症治疗引起皮肤不良事件, enTitle=Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel., guiderFrom=An Bras Dermatol. 2020 Feb 15, authorId=0, author=, summary=随着肿瘤治疗方法的不断发展,全身性毒性对生存率的影响得到了改善。不过值得注意的是皮肤不良事件。本文主要针对肿瘤治疗过程中引起的皮肤不良事件的管理提出指导建议。, cover=https://img.medsci.cn/Random/147963-wrist-pain.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Feb 15 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>随着肿瘤治疗方法的不断发展,全身性毒性对生存率的影响得到了改善。不过值得注意的是皮肤不良事件。本文主要针对肿瘤治疗过程中引起的皮肤不良事件的管理提出指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2836, tagName=癌症治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=516, guiderKeyword=癌症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1146, appHits=55, showAppHits=0, pcHits=301, showPcHits=1096, likes=0, shares=4, comments=1, approvalStatus=1, publishedTime=Tue Mar 24 00:32:09 CST 2020, publishedTimeString=2020-02-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Mar 24 00:12:16 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 18:52:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=804231, encodeId=c97980423148, content=请问怎么积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9545402492, createdName=默默, createdTime=Fri Jul 24 00:41:57 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381065, encodeId=13ce38106554, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 28 09:26:35 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2020-07-24 默默

    请问怎么积分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=804231, encodeId=c97980423148, content=请问怎么积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9545402492, createdName=默默, createdTime=Fri Jul 24 00:41:57 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381065, encodeId=13ce38106554, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/10/79695518fa5744eb6dc56904a3897914.jpg, createdBy=4ad15254155, createdName=MYcat124, createdTime=Sat Mar 28 09:26:35 CST 2020, time=2020-03-28, status=1, ipAttribution=)]
    2020-03-28 MYcat124

    学习了

    0

拓展阅读

2014年ASCO 美国成人癌症幸存者疲劳的筛查和管理指南

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2014-04-14

2014 ASE/EACI专家共识:多峰性成像技术评估成人患者癌症治疗期间及之后

美国超声心动图学会(ASE,American Society of Echocardiography) · 2014-07-12

2014 COSA立场声明:癌症患者补充和替代疗法的应用

澳大利亚临床肿瘤学会(COSA,Clinical Oncology Society of Australia) · 2014-09-22

2014 ASCO官方声明:一期试验在 研究和治疗中的重要作用

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2014-12-15

2015 ISTH指南:癌症相关的弥散性血管内凝血的管理

国际血栓与止血学会(ISTH,International Society on Thrombosis and Haemostasis) · 2015-01-05

2014 ASCO 癌症患者静脉血栓栓塞防治指南(更新版)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2015-01-20